e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Pulmonary manifestations of systemic diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Patients with tissue hypoxia with unknown origin
Y. To, K. Araki, Y. Kono, M. To (Tokyo, Koshigaya, Japan)
Source:
Annual Congress 2012 - Pulmonary manifestations of systemic diseases
Session:
Pulmonary manifestations of systemic diseases
Session type:
Oral Presentation
Number:
3126
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. To, K. Araki, Y. Kono, M. To (Tokyo, Koshigaya, Japan). Patients with tissue hypoxia with unknown origin. Eur Respir J 2012; 40: Suppl. 56, 3126
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Post partum
dyspnoea: look beyond the lungs
CARDIAC DYSFUNCTION IN ACTIVE PULMONARY TUBERCULOSIS: DOUBLE TROUBLE!!
Related content which might interest you:
Features of pulmonary involvement in patients with diffuse connective tissue diseases depending on a nosological form
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011
Does lung function predict response to therapy in PAH associated with connective tissue disease?
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012
Features of pulmonary involvement in patients with diffuse connective tissue diseases
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011
An ocular lesion of unknown aetiology
Source: Breathe, 17 (2) 200164; 10.1183/20734735.0164-2020
Year: 2021
Hypoxic phenotype in pulmonary metastases of different primary tumors
Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Year: 2012
The nature of inflammation and tissue damage in COPD
Source: Annual Congress 2004 - Acquired somatic mutations in the pathogenesis of COPD
Year: 2004
Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015
The effect of hypoxia and re-oxygenation on adipose tissue lipolysis in COPD patients
Source: Eur Respir J 2016; 48: 1218-1220
Year: 2016
The clinical spectrum and pathogenesis of pulmonary manifestations in connective tissue diseases
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=1
Year: 2005
Evaluation and treatment of interstitial lung involvement in connective tissue diseases: a clinical update
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=27
Year: 2005
Fibroblasts from IPF explanted lungs have mitochondrial dysfunction and short telomeres leading to an increased senescence phenotype
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Acute effects of oxygen on pulmonary hemodynamic can help in differentiation of pulmonary hypertension at patients with connective tissue diseases
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Peculiarities of cytokine status of patients with infiltrative pulmonary tuberculosis associated with connective tissue dysplasia
Source: Eur Respir J 2004; 24: Suppl. 48, 645s
Year: 2004
Unclassifiable interstitial lung disease: a distinct entity with heterogeneous progression
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018
Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Expression of hyaluronidase by interstitial myofibroblasts and epithelial cells is associated with fibrosis extension, clinical forms and pulmonary function stage in patients with systemic sclerosis
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin
Source: Eur Respir J 2001; 18: 17S-29S
Year: 2001
Undifferentiated connective tissue disease at risk for systemic sclerosis: is heart function already impaired?
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Impaired cerebral oxygenation: a cause for exercise intolerance in patients with fibrotic interstitial lung disease?
Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease
Year: 2020
Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis. A tissue doppler imaging study
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept